Swiss National Bank’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$71.2M Buy
120,055
+2,320
+2% +$1.16M 0.04% 358
2025
Q4
$57.4M Sell
117,735
-5,720
-5% -$2.66M 0.03% 383
2025
Q3
$51.8M Sell
123,455
-5,600
-4% -$1.88M 0.03% 426
2025
Q2
$37.1M Buy
129,055
+9,500
+8% +$2.84M 0.02% 496
2025
Q1
$36.9M Buy
119,555
+100
+0.1% +$34.3K 0.03% 483
2024
Q4
$42.1M Sell
119,455
-5,600
-4% -$2.06M 0.03% 464
2024
Q3
$44.8M Sell
125,055
-7,300
-6% -$2.47M 0.03% 470
2024
Q2
$42.2M Sell
132,355
-8,300
-6% -$2.2M 0.03% 454
2024
Q1
$32.3M Sell
140,655
-6,100
-4% -$1.38M 0.02% 536
2023
Q4
$32.3M Sell
146,755
-3,900
-3% -$899K 0.02% 535
2023
Q3
$34M Sell
150,655
-16,500
-10% -$3.8M 0.03% 514
2023
Q2
$36.9M Sell
167,155
-13,800
-8% -$3.06M 0.03% 526
2023
Q1
$40.5M Buy
180,955
+71,055
+65% +$17.5M 0.03% 509
2022
Q4
$30.6M Buy
109,900
+2,500
+2% +$631K 0.02% 557
2022
Q3
$22.5M Buy
107,400
+1,000
+0.9% +$224K 0.02% 606
2022
Q2
$25.1M Sell
106,400
-100
-0.1% -$20.3K 0.02% 592
2022
Q1
$19.1M Buy
106,500
+7,800
+8% +$1.49M 0.01% 696
2021
Q4
$21.3M Sell
98,700
-200
-0.2% -$39.3K 0.01% 672
2021
Q3
$18.3M Buy
98,900
+700
+0.7% +$138K 0.01% 707
2021
Q2
$17.6M Sell
98,200
-3,400
-3% -$648K 0.01% 742
2021
Q1
$17M Buy
101,600
+1,200
+1% +$200K 0.01% 734
2020
Q4
$15.2M Buy
100,400
+600
+0.6% +$78.7K 0.01% 736
2020
Q3
$10.1M Buy
99,800
+1,900
+2% +$208K 0.01% 799
2020
Q2
$11.8M Buy
97,900
+12,800
+15% +$1.44M 0.01% 713
2020
Q1
$8.07M Buy
85,100
+1,200
+1% +$114K 0.01% 731
2019
Q4
$7.39M Buy
83,900
+1,400
+2% +$123K 0.01% 925
2019
Q3
$6.58M Buy
82,500
+2,500
+3% +$201K 0.01% 950
2019
Q2
$6.25M Sell
80,000
-65,200
-45% -$6.1M 0.01% 978
2019
Q1
$17M Buy
145,200
+3,700
+3% +$431K 0.02% 606
2018
Q4
$15.4M Buy
141,500
+2,400
+2% +$278K 0.02% 586
2018
Q3
$17.8M Sell
139,100
-3,900
-3% -$482K 0.02% 601
2018
Q2
$16.2M Buy
143,000
+3,300
+2% +$363K 0.02% 610
2018
Q1
$15.7M Sell
139,700
-21,900
-14% -$2.78M 0.02% 611
2017
Q4
$23.9M Sell
161,600
-4,000
-2% -$508K 0.03% 572
2017
Q3
$19.4M Buy
165,600
+1,600
+1% +$204K 0.02% 583
2017
Q2
$21.3M Buy
164,000
+13,700
+9% +$1.71M 0.03% 579
2017
Q1
$20.3M Buy
150,300
+28,900
+24% +$4.38M 0.03% 570
2016
Q4
$17.4M Sell
121,400
-2,700
-2% -$345K 0.03% 562
2016
Q3
$14.7M Sell
124,100
-3,000
-2% -$360K 0.02% 573
2016
Q2
$13.5M Buy
127,100
+8,400
+7% +$937K 0.02% 589
2016
Q1
$12.7M Buy
118,700
+36,000
+44% +$4.56M 0.02% 580
2015
Q4
$13M Buy
82,700
+200
+0.2% +$29.1K 0.03% 519
2015
Q3
$10.8M Buy
82,500
+7,200
+10% +$1.15M 0.03% 545
2015
Q2
$13.1M Buy
75,300
+21,400
+40% +$3.85M 0.03% 508
2015
Q1
$9.29M Buy
53,900
+700
+1% +$107K 0.02% 578
2014
Q4
$6.89M Buy
53,200
+2,600
+5% +$335K 0.03% 573
2014
Q3
$6.51M Sell
50,600
-3,000
-6% -$309K 0.03% 573
2014
Q2
$4.74M Hold
53,600
0.02% 750
2014
Q1
$5.04M Buy
53,600
+12,000
+29% +$1.23M 0.02% 701
2013
Q4
$4.7M Buy
41,600
+400
+1% +$36.1K 0.02% 640
2013
Q3
$3.25M Sell
41,200
-1,100
-3% -$80.4K 0.01% 755
2013
Q2
$2.78M Buy
+42,300
New +$2.72M 0.01% 809

Other funds holding UTHR